Ardent Health Partners, LLC (ARDT) Revenue History
Annual and quarterly revenue from 2016 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
ARDT's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
ARDT Revenue Analysis (2016–2024)
As of March 1, 2026, Ardent Health Partners, LLC (ARDT) generated trailing twelve-month (TTM) revenue of $6.33 billion, reflecting solid growth of +8.8% year-over-year. The most recent quarter (Q3 2025) recorded $1.58 billion in revenue, down 4.2% sequentially.
Looking at the longer-term picture, ARDT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $5.97 billion in 2024, representing a new all-time high.
Revenue diversification analysis shows ARDT's business is primarily driven by Reportable Segment (100%). With over half of revenue concentrated in Reportable Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HCA (+7.1% YoY), THC (+3.1% YoY), and MPW (-2.7% YoY), ARDT has outperformed the peer group in terms of revenue growth. Compare ARDT vs HCA →
Peer Comparison
Compare ARDT's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ARDTCurrent | $6.3B | +8.8% | - | 6.8% | |
| HCA | $75.6B | +7.1% | +8.0% | 15.8% | |
| THC | $21.3B | +3.1% | +3.9% | 16.5% | |
| MPW | $972M | -2.7% | -4.9% | - | |
| ACHC | $3.3B | +5.0% | +9.7% | 11.7% | |
| CYH | $12.5B | -1.2% | +1.2% | 11.9% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $5.97B | +10.3% | $4.93B | 82.7% | $405.8M | 6.8% |
| 2023 | $5.41B | +5.5% | $5.27B | 97.4% | $229.5M | 4.2% |
| 2022 | $5.13B | +23.3% | $4.17B | 81.4% | $217.0M | 4.2% |
| 2018 | $4.16B | +38.6% | $4.16B | 100.0% | $149.8M | 3.6% |
| 2017 | $3.00B | +42.6% | $3.00B | 100.0% | $121.8M | 4.1% |
| 2016 | $2.11B | - | $2.11B | 100.0% | $84.8M | 4.0% |
See ARDT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARDT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ARDT vs AGIO
See how ARDT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ARDT's revenue growth accelerating or slowing?
ARDT maintains +8.8% revenue growth, in line with its 5-year CAGR of N/A. TTM revenue stands at $6.3B. Growth rate remains consistent with historical average.
What is ARDT's long-term revenue growth rate?
Ardent Health Partners, LLC's 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +8.8% is near this long-term average.
How is ARDT's revenue distributed by segment?
ARDT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2024 are available for download. Segment mix reveals concentration and diversification trends.